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Demographic Characteristics
BMI Categories GWG Adherence Categories
Underweight
-Normal
Overwgt-
Obese
P-Value
Under/Appropr
Gain
Over-Gain
P-ValueMean±SD Mean±SD Mean±SD Mean±SD
Age (years) 25.9±8.5 31.1±6.6 0.01 29.6±7.9 29.5±7.4 NS
Gravity 2.4±1.7 2.9±1.8 NS 2.9±2.1 2.7±1.5 NS
Living Children 0.8±1.1 1.0±1.0 NS 0.9±1.1 0.9±1.0 NS
GA @ first PNV (wk) 11.8±4.4 12.0±6.0 NS 11.8±4.8 12.0±6.3 NS
SBP @ first PNV (mmHg) 114.0±12.5 119.5±13.7 NS 117.1±14.2 119.1±13.1 NS
DBP at first PNV (mmHg) 67.1±5.1 70.8±9.6 NS 70.0±8.4 69.9±9.4 NS
GA at delivery (wks) 38.6±2.2 38.0±2.7 NS 38.6±2.0 37.9±2.8 NS
Placenta weight (g) 443.8±90.1 443.6±206.9 NS 526.4±155.7 371.3±176.2 NS
N (%) N (%) N (%) N (%)
Race/ethnicity
White
Hispanic
Black
Other
13 (54.2)
10 (41.7)
0 (0)
1 (4.2)
35 (60.3)
13 (22.4)
9 (15.5)
1 (1.7)
0.05
19 (55.9)
10 (29.4)
4 (11.8)
1 (2.9)
29 (60.4)
13 (27.1)
5 (10.4)
1 (2.9)
NS
Smoking Status
Current
Prior Pregnancy
Never
1 (4.2)
6 (25.0)
17 (70.3)
6 (10.3)
9 (15.5)
43 (74.1)
NS
4 (11.8)
5 (14.7)
25 (73.5)
3 (6.3)
10 (20.8)
35 (72.9)
NS
Chronic HTN 3 (12.5) 17 (29.3) NS 9 (26.5) 11 (22.9) NS
Pregestational DM 6 (25.0) 22 (37.9) NS 10 (29.4) 18 (37.5) NS
Renal Disease 4 (16.7) 1 (1.7) 0.02 5 (14.7) 0 (0) 0.01
Adolescent Pregnancy 8 (33.3) 6 (10.3) 0.02 7 (20.6) 7 (14.6) NS
History Preeclampsia 4 (16.7) 9 (15.5) NS 7 (20.6) 6 (12.5) NS
Lupus 4 (16.7) 2 (3.5) NS 4 (11.8) 2 (4.2) NS
Antiphospholipid Syndrome 0 (0) 2 (3.5) NS 0 (0) 2 (4.2) NS
• In May 2009, after considering short and long-term maternal/child outcomes, 
the Institute of Medicine (IOM) revised recommendations for gestational weight gain 
(GWG); however preeclampsia was dismissed due to insufficient evidence. 
IOM 2009
• Since change in recommendations, epidemiologic studies have since been 
published that support an association between GWG adherence and hypertensive 
disease of pregnancy.
AJOG 2009;200(2):167.e1-7
• Numerous studies have revealed adipose tissue's ability to stimulate 
angiogenesis
Cardiovascular Res 2008;78(2):286-93
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Background
Materials & Methods
Objective
Limitations
Results
To evaluate preeclampsia risk by angiogenic-biomarker profile by                         
both BMI and GWG-adherence.
We hypothesized that overweight/obese (OW-OB) women and over-gainers (OG) 
would have altered angiogenic profiles as compared to underweight/normal-
weight (U-N) women and under-/appropriate-gainers (U-AG), respectively.
 Pregnant subjects  <24 weeks gestation enrolled from outpatient prenatal clinics at UMass 
Memorial Health Care between May 2004 and January 2006.
 Each subject had >1 of the following risk factors for preeclampsia:
Inclusion Criteria                       RR
Chronic HTN 2.37
Renal Disease/CKD -----
Pregestational DM  3.56
History of Preeclampsia              7.19
Teen Pregnancy (≤ 18)                2.98
Multi-fetal gestation    2.93 (twins)
2.83 (triplets)
Obesity (BMI > 30)     2.47
APL Ab Syndrome                      9.72
SLE -----
Duckitt K & Harrington D. BMJ. 2005
 Subjects recruited 127
Exclusions
missing outcomes 3
gestational HTN  5
multiple gestationsa 25
preeclampsia diagnosisb 12
Subjects included in analyses              82 (342 samples)
Excluded due to association with altered angiogenic profile:
aMultiple gestations (n=20)  Maynard et al, AJOG, 2008;198:200
bHypertensive diseases of pregnancy (gestational HTN & preeclampsia) Moore Simas et al, AJOG, 2007;197:244.e1-244.e8
 sFlt1, PlGF and sEndoglin levels were measured by ELISA
 BMI & GWG adherence categories by 1990 IOM recommendations
Adherence defined by GWG and GA @ last prenatal visit subtracted from pre-pregnancy weight; 
thus preterm and term deliveries included
Statistical Analysis
 Demographic comparisons utilized Fisher exact test for categorical variables and Wilcoxon
rank sum test for continuous variables  (see Table 1)
 Within-women correlation and right-skewness handled by estimating linear mixed models 
for ln-transformed biomarkers and then exponentiating on ln scale (i.e., geometric means). 
 Geometric mean and 95% confidence intervals displayed for sFlt1, PlGF and 
(sFlt1+sEng):PlGF in each of 3 gestational-age windows for UW-N vs. OW-OB BMI and 
Under-Appropriate vs. Over-gainers (see figures 1-6)
 T-test compared means in 3 windows.  
Pre-pregnancy BMI Category
Pre-pregnancy BMI* 
(kg/m2)
Total GWG at 40 weeks
Underweight (U) <19.8 28-40 lbs
Normal weight  (N) 19.8-26.0 25-35 lbs
Overweight (OW) 26.1-29.0 15-25 lbs
Obese (OB) >29.0 At least 15 lbs
• Analytic sample included 82 subjects (342 specimens). See Table 1 for Demographic Comparisons.
• BMI Comparisons (see Figures1–3)
o Mean sFlt1 lower in all windows in OW-OB compared to U-N (Figure 1)
o Mean PlGF lower in all windows in OW-OB compared to U-N (Figure 2)
o Mean ratio [(sFlt1+sEng):PlGF] trended higher in OW-OB compared to 
U-N women at 27-30 and 31-36wks (Figure 3)
• GWG Adherence Comparisons (see Figures 4–6)
o Mean sFlt1 lower in all windows in OG compared to U-AG (Figure 4)
o Mean PLGF lower in all windows in OG compared to U-AG (Figure 5)
o Mean ratio [(sFlt1+sEng):PlGF] trended higher in OG compared 
to U-AG at 31-36wks (Figure 6)
Hypothesis
Table 1. Demographic comparisons
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Figures 1-3.  Angiogenic biomarker profiles comparing under-/normal-weight to overweight/obese at 3 gestational age windows 
BMI Category
(# specimen/ # women)
22-26 weeks 27-30 weeks 31-36 weeks
Underweight (<19.8) 5/4 6/3 7/4
Normal weight (19.8-26.0) 22/18 27/18 29/17
Overweight (26.0-29.0) 22/16 23/15 28/14
Obese (>29.0) 47/35 63/37 63/36
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GWG BMI-specific 
Adherence Category
(# specimen/ # women)
22-26 weeks 27-30 weeks 31-36 weeks
Under gainer 24/17 24/15 27/14
Appropriate gainer 18/13 25/15 29/15
Over gainer 54/43 70/43 71/42
Figures 4-6.  Angiogenic biomarker profiles comparing under/appropriate gainers to over-gainers at 3 gestational age windows 
• Small sample size required collapsing of BMI and 
GWG-adherence categories; thus unable to look 
at adherence within each BMI category
• Secondary analysis not powered for this 
exploratory analysis
• Only had total GWG at end of pregnancy
